Resonance Health Ltd (AU:RHT) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Resonance Health Ltd reports significant growth with a record $3.77M in customer receipts, marking a 228% increase from the previous quarter, and announces major milestones including nearly completed patient recruitment for a clinical trial and successful acquisition and integration of TrialsWest. The company also notes a robust cash balance of $6.85M, driven by strong operational performance and milestone payments from their clinical research organization business.
For further insights into AU:RHT stock, check out TipRanks’ Stock Analysis page.